Brand Name: POMBILITI Generic Name: (cipaglucosidase alfa-atga)
POMBILITI (cipaglucosidase alfa-atga) is used to treat late-onset Pompe disease
Pombiliti is a medicine used to treat adults with late-onset Pompe disease (acid alpha-glucosidase [GAA] deficiency), an inherited disorder in which patients have breathing difficulties and muscle weakness. Pombiliti is used in combination with another medicine, miglustat. Pombiliti contains the active substance cipaglucosidase alfa.
| Brand Name: | POMBILITI |
| Generic Name: | cipaglucosidase alfa-atga |
| Strength: | For injection: 105 mg of cipaglucosidase alfa-atga as a lyophilized powder in a single-dose vial for reconstitution. |
| Manufacturer: | Amicus Therapeutics |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “POMBILITI (cipaglucosidase alfa-atga)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for POMBILITI (cipaglucosidase alfa-atga) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
